Contact the care team because medication side effects and nutrition risk need clinical judgment
The result: faster results, better sustainability, and fewer people who regain the weight after stopping because weve addressed the root dysfunction, not just suppressed appetite
However, Januvia offers distinct advantages: oral administration versus injection, lower cost, and fewer gastrointestinal side effects
The FDA approval of the first oral GLP-1 medication for obesity in December 2025 represents a major milestone in weight loss treatment options
These appetite-regulating effects are considered one of the primary reasons behind the remarkable weight-loss outcomes observed throughout both the SURMOUNT and SURPASS clinical programs
In contrast, methylcobalamin and adenosylcobalamin are already in active states, allowing for immediate cellular use